Insufficient scRNA-seq data for expression of WFIKKN1 at single-cell level.
Insufficient scRNA-seq data for expression of WFIKKN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 323.53 | 2600 / 2642 | 81% | 2.44 | 569 / 705 |
prostate | 95% | 241.00 | 233 / 245 | 53% | 1.16 | 264 / 502 |
kidney | 99% | 214.00 | 88 / 89 | 47% | 1.56 | 425 / 901 |
uterus | 95% | 112.22 | 162 / 170 | 36% | 0.94 | 167 / 459 |
ovary | 94% | 172.82 | 170 / 180 | 31% | 0.78 | 135 / 430 |
pancreas | 93% | 134.46 | 306 / 328 | 26% | 0.54 | 47 / 178 |
thymus | 98% | 226.90 | 642 / 653 | 21% | 0.93 | 128 / 605 |
lung | 91% | 124.33 | 525 / 578 | 24% | 0.56 | 272 / 1155 |
intestine | 78% | 73.85 | 756 / 966 | 30% | 0.66 | 158 / 527 |
stomach | 80% | 87.35 | 288 / 359 | 23% | 0.44 | 67 / 286 |
liver | 85% | 83.59 | 193 / 226 | 15% | 0.27 | 60 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.14 | 1 / 1 |
bladder | 71% | 53.00 | 15 / 21 | 26% | 0.60 | 133 / 504 |
spleen | 96% | 108.14 | 232 / 241 | 0% | 0 | 0 / 0 |
esophagus | 55% | 38.01 | 793 / 1445 | 41% | 1.13 | 75 / 183 |
breast | 62% | 51.24 | 285 / 459 | 30% | 0.62 | 330 / 1118 |
adrenal gland | 36% | 22.77 | 93 / 258 | 48% | 1.09 | 111 / 230 |
skin | 73% | 155.19 | 1315 / 1809 | 7% | 0.13 | 32 / 472 |
muscle | 74% | 89.82 | 592 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 55% | 35.66 | 737 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 49% | 38.80 | 455 / 929 | 0% | 0 | 0 / 0 |
adipose | 45% | 27.54 | 536 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 44% | 0.83 | 20 / 45 |
heart | 38% | 19.88 | 328 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.14 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001501 | Biological process | skeletal system development |
GO_0060021 | Biological process | roof of mouth development |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0055001 | Biological process | muscle cell development |
GO_0005615 | Cellular component | extracellular space |
GO_0048019 | Molecular function | receptor antagonist activity |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | WFIKKN1 |
Protein name | WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 (Growth and differentiation factor-associated serum protein 2) (GASP-2) (hGASP-2) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing protein) |
Synonyms | WFIKKN PSEC0040 C16orf12 GASP2 |
Description | FUNCTION: Protease-inhibitor that contains multiple distinct protease inhibitor domains. Probably has serine protease- and metalloprotease-inhibitor activity (By similarity). . |
Accessions | Q96NZ8 ENST00000319070.3 |